vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Riley Exploration Permian, Inc. (REPX). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $97.3M, roughly 1.4× Riley Exploration Permian, Inc.). On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -5.3%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs -1.2%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

CTRE vs REPX — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.4× larger
CTRE
$134.9M
$97.3M
REPX
Growing faster (revenue YoY)
CTRE
CTRE
+60.4% gap
CTRE
55.1%
-5.3%
REPX
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
-1.2%
REPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
REPX
REPX
Revenue
$134.9M
$97.3M
Net Profit
$111.3M
Gross Margin
Operating Margin
26.9%
Net Margin
82.5%
Revenue YoY
55.1%
-5.3%
Net Profit YoY
113.5%
EPS (diluted)
$0.52
$4.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
REPX
REPX
Q4 25
$134.9M
$97.3M
Q3 25
$132.4M
$106.9M
Q2 25
$112.5M
$85.4M
Q1 25
$96.6M
$102.5M
Q4 24
$86.9M
$102.7M
Q3 24
$77.4M
$102.3M
Q2 24
$68.9M
$105.4M
Q1 24
$63.1M
$99.7M
Net Profit
CTRE
CTRE
REPX
REPX
Q4 25
$111.3M
Q3 25
$74.9M
$16.3M
Q2 25
$68.5M
$30.5M
Q1 25
$65.8M
$28.6M
Q4 24
$52.1M
Q3 24
$33.4M
$25.7M
Q2 24
$10.8M
$33.5M
Q1 24
$28.7M
$18.8M
Operating Margin
CTRE
CTRE
REPX
REPX
Q4 25
26.9%
Q3 25
58.1%
27.0%
Q2 25
61.3%
33.7%
Q1 25
48.3%
Q4 24
31.2%
Q3 24
43.0%
17.1%
Q2 24
15.1%
50.9%
Q1 24
50.7%
Net Margin
CTRE
CTRE
REPX
REPX
Q4 25
82.5%
Q3 25
56.6%
15.3%
Q2 25
60.9%
35.7%
Q1 25
68.1%
27.9%
Q4 24
60.0%
Q3 24
43.2%
25.1%
Q2 24
15.6%
31.8%
Q1 24
45.6%
18.8%
EPS (diluted)
CTRE
CTRE
REPX
REPX
Q4 25
$0.52
$4.02
Q3 25
$0.35
$0.77
Q2 25
$0.35
$1.44
Q1 25
$0.35
$1.36
Q4 24
$0.30
$0.52
Q3 24
$0.21
$1.21
Q2 24
$0.07
$1.59
Q1 24
$0.22
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
REPX
REPX
Cash + ST InvestmentsLiquidity on hand
$198.0M
Total DebtLower is stronger
$894.2M
$247.9M
Stockholders' EquityBook value
$4.0B
$634.2M
Total Assets
$5.1B
$1.2B
Debt / EquityLower = less leverage
0.22×
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
REPX
REPX
Q4 25
$198.0M
Q3 25
$712.5M
Q2 25
$306.1M
Q1 25
$26.5M
Q4 24
$213.8M
Q3 24
$377.1M
Q2 24
$495.1M
Q1 24
$451.2M
Total Debt
CTRE
CTRE
REPX
REPX
Q4 25
$894.2M
$247.9M
Q3 25
$893.8M
$367.0M
Q2 25
$1.2B
$275.2M
Q1 25
$822.1M
$249.3M
Q4 24
$396.9M
$269.5M
Q3 24
$396.7M
$288.6M
Q2 24
$671.1M
$322.7M
Q1 24
$595.9M
$341.8M
Stockholders' Equity
CTRE
CTRE
REPX
REPX
Q4 25
$4.0B
$634.2M
Q3 25
$4.0B
$566.5M
Q2 25
$3.3B
$556.9M
Q1 25
$2.9B
$532.4M
Q4 24
$2.9B
$510.6M
Q3 24
$2.4B
$507.4M
Q2 24
$1.9B
$489.0M
Q1 24
$1.7B
$434.6M
Total Assets
CTRE
CTRE
REPX
REPX
Q4 25
$5.1B
$1.2B
Q3 25
$5.1B
$1.2B
Q2 25
$4.7B
$1.0B
Q1 25
$3.9B
$994.9M
Q4 24
$3.4B
$993.5M
Q3 24
$2.9B
$997.9M
Q2 24
$2.7B
$1.0B
Q1 24
$2.3B
$956.4M
Debt / Equity
CTRE
CTRE
REPX
REPX
Q4 25
0.22×
0.39×
Q3 25
0.22×
0.65×
Q2 25
0.35×
0.49×
Q1 25
0.28×
0.47×
Q4 24
0.14×
0.53×
Q3 24
0.16×
0.57×
Q2 24
0.35×
0.66×
Q1 24
0.36×
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
REPX
REPX
Operating Cash FlowLast quarter
$394.0M
$64.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
REPX
REPX
Q4 25
$394.0M
$64.9M
Q3 25
$100.9M
$63.6M
Q2 25
$100.8M
$33.6M
Q1 25
$71.4M
$50.4M
Q4 24
$244.3M
$66.4M
Q3 24
$67.2M
$72.1M
Q2 24
$53.0M
$51.6M
Q1 24
$48.8M
$56.1M
Cash Conversion
CTRE
CTRE
REPX
REPX
Q4 25
3.54×
Q3 25
1.35×
3.90×
Q2 25
1.47×
1.10×
Q1 25
1.08×
1.76×
Q4 24
4.68×
Q3 24
2.01×
2.81×
Q2 24
4.92×
1.54×
Q1 24
1.70×
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons